Cytophage Technologies

Cytophage Technologies is a Canadian biotechnology company dedicated to developing synthetic bacteriophages to combat the global crisis of antibiotic resistance. The company utilizes a proprietary synthetic biology platform to engineer "tempered" phages that are highly specific, stable, and capable of overcoming the natural defense mechanisms of pathogenic bacteria. Their product pipeline addresses critical needs across human health, animal health, and food safety, with applications ranging from treating urinary tract infections to preventing necrotic enteritis in livestock. By providing a scalable and customizable alternative to traditional antibiotics, Cytophage aims to transform the management of infectious diseases in both clinical and agricultural settings.